Prenetics Global Limited (PRE)
NASDAQ: PRE · Real-Time Price · USD
23.25
+1.43 (6.55%)
At close: Aug 25, 2026, 4:00 PM EDT
22.99
-0.26 (-1.12%)
After-hours: Aug 25, 2026, 6:39 PM EDT
Company Description
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong.
The company focuses on advancing human health and longevity through science-backed products under the IM8 brand.
It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories.
The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Prenetics Global Limited
| Country | Hong Kong |
| Founded | 2014 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 98 |
| CEO | Sheng Wu Yeung |
Contact Details
Address: Unit 703-706, K11 Atelier King’s Road, 728 King’s Road Quarry Bay Hong Kong | |
| Phone | 852 2210 9588 |
| Website | prenetics.com |
Stock Details
| Ticker Symbol | PRE |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001876431 |
| CUSIP Number | G72245122 |
| ISIN Number | KYG722451229 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sheng Wu Yeung | Co-Founder, Chairperson and Chief Executive Officer |
| Samantha Kwok | Chief of Staff and Vice President of People & Operations |
| Dr. Senthil Kumar Sundaram M.D. | Chief Clinical Officer |
| Brian J. Rosin | Chief Financial Officer of U.S. |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 21, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Aug 20, 2026 | 6-K | Report of foreign issuer |
| Aug 18, 2026 | 6-K | Report of foreign issuer |
| Aug 17, 2026 | 6-K | Report of foreign issuer |
| Aug 7, 2026 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Aug 7, 2026 | 6-K | Report of foreign issuer |
| Jul 30, 2026 | 20-F/A | Filing |
| Jul 14, 2026 | 6-K | Report of foreign issuer |
| Jul 2, 2026 | 20-F/A | Filing |
| Jun 10, 2026 | 6-K | Report of foreign issuer |